| Medical and Health Sciences | 2021-2025 | 172 | DK 3 | 99.97 |
| Dermatology | Lifetime | 17 | DK 2 | 99.85 |
| Immunology and Allergy | Lifetime | 61 | DK 2 | 99.02 |
| Dermatology | 2021-2025 | 5 | DK 1 | 99.94 |
| Immunology and Allergy | 2021-2025 | 7 | DK 1 | 99.57 |
| Medical Physiology | 2021-2025 | 386 | DK 7 | 94.66 |
| Rheumatology | 2021-2025 | 388 | DK 7 | 83.72 |
| Immunology | 2021-2025 | 642 | DK 7 | 81.00 |
| Contact Dermatitis and Allergies | Lifetime | 4 | DK 1 | 99.81 |
| Occupational exposure and asthma | Lifetime | 5 | DK 1 | 99.64 |
| Allergic Rhinitis and Sensitization | Lifetime | 39 | DK 1 | 99.74 |
| Dermatology and Skin Diseases | Lifetime | 38 | DK 1 | 99.71 |
| Food Allergy and Anaphylaxis Research | Lifetime | 42 | DK 2 | 99.56 |
| Immunotoxicology and immune responses | Lifetime | 14 | DK 3 | 98.84 |
| Asthma and respiratory diseases | Lifetime | 451 | DK 10 | 98.89 |
| Acne and Rosacea Treatments and Effects | Lifetime | 53 | DK 3 | 98.64 |
| Pesticide Exposure and Toxicity | Lifetime | 129 | DK 5 | 98.04 |
| Urticaria and Related Conditions | Lifetime | 179 | DK 3 | 98.21 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 194 | DK 7 | 98.36 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | Lifetime | 222 | DK 12 | 97.66 |
| Drug-Induced Adverse Reactions | Lifetime | 214 | DK 7 | 96.78 |
| Pharmacological Effects of Natural Compounds | Lifetime | 836 | DK 3 | 95.31 |
| melanin and skin pigmentation | Lifetime | 903 | DK 5 | 92.91 |
| Agricultural safety and regulations | Lifetime | 271 | DK 12 | 84.86 |
| Biomedical and Chemical Research | Lifetime | 542 | DK 14 | 82.07 |
| Historical Medical Research and Treatments | Lifetime | 187 | DK 5 | 83.30 |
| Historical and Scientific Studies | Lifetime | 509 | DK 3 | 79.84 |
| Hidradenitis Suppurativa and Treatments | Lifetime | 535 | DK 33 | 77.62 |
| Tattoo and Body Piercing Complications | Lifetime | 317 | DK 11 | 67.99 |
| Allergic Rhinitis and Sensitization | 2021-2025 | 5 | DK 1 | 99.88 |
| Dermatology and Skin Diseases | 2021-2025 | 5 | DK 1 | 99.85 |
| Contact Dermatitis and Allergies | 2021-2025 | 2 | DK 1 | 99.79 |
| Food Allergy and Anaphylaxis Research | 2021-2025 | 5 | DK 1 | 99.69 |
| Asthma and respiratory diseases | 2021-2025 | 32 | DK 2 | 99.53 |
| Occupational exposure and asthma | 2021-2025 | 31 | DK 3 | 93.26 |
| Acne and Rosacea Treatments and Effects | 2021-2025 | 53 | DK 2 | 94.19 |
| Urticaria and Related Conditions | 2021-2025 | 134 | DK 2 | 94.31 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 153 | DK 2 | 91.59 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 409 | DK 11 | 90.96 |
| Pharmaceutical studies and practices | 2021-2025 | 393 | DK 7 | 84.50 |
| Pharmacological Effects of Natural Compounds | 2021-2025 | 723 | DK 1 | 81.80 |
| Hidradenitis Suppurativa and Treatments | 2021-2025 | 227 | DK 12 | 78.65 |
| Transgenic Plants and Applications | 2021-2025 | 386 | DK 1 | 69.72 |
| Chemotherapy-related skin toxicity | 2021-2025 | 870 | DK 23 | 28.47 |
